NIFTY 50▼24,406.10
-7.40 (-0.03%)
SENSEX▼80,039.80
-109.08 (-0.14%)
NIFTY BANK▼50,888.75
-428.25 (-0.83%)
INDIAN RAILWAY FINANCE CORP▼183.56
-8.71 (-4.53%)
TATA MOTORS▲1,090.95
63.25 (6.15%)
TATA STEEL▼157.39
-2.92 (-1.82%)
TATA POWER▲423.35
3.40 (0.81%)
SUZLON ENERGY▲61.47
0.75 (1.24%)
RAIL VIKAS NIGAM▼575.70
-18.05 (-3.04%)
INDIAN RENEWABLE ENERGY▼261.18
-8.08 (-3.00%)
VODAFONE IDEA▼15.18
-0.40 (-2.57%)
RELIANCE INDUSTRIES▼2,984.80
-6.60 (-0.22%)
YES BANK▼24.62
-0.28 (-1.12%)
ADANI POWER▲695.20
0.50 (0.07%)
NHPC▼101.96
-0.42 (-0.41%)
STATE BANK OF INDIA▼848.50
-3.50 (-0.41%)
HDFC BANK▲1,616.60
12.55 (0.78%)
RELIANCE POWER▲29.69
1.41 (4.99%)
JIO FIN SERVICES LTD▼329.20
-5.50 (-1.64%)
ZOMATO▼219.31
-4.18 (-1.87%)
ADANI PORT & SEZ▲1,487.00
2.20 (0.15%)
BHARAT ELECTRONICS▲301.45
1.35 (0.45%)
INDIAN RAILWAY TOURISM CORP▼969.15
-5.05 (-0.52%)
INDIAN OIL CORP▲176.85
8.06 (4.78%)
RATTANINDIA POWER▲16.81
0.80 (5.00%)
MRF▲1,37,590.10
317.45 (0.23%)
ADANI ENTERPRISES▲2,973.50
2.80 (0.09%)
JAIPRAKASH POWER VENTURES▲18.83
0.03 (0.16%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/NSE_EQ|INE03QK01018.png)
Suven Pharmaceuticals Share Price
SUVENPHAR
₹912.45+₹32.15 (3.65%) TodayLast updated on 25 Jul, 2024 | 15:57 IST
₹866.20₹922.90
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹872.30 | Close₹880.30 |
Circuit range₹1,056.35 - ₹704.25 | Day range₹866.20 - ₹922.90 | Year range₹481.65 - ₹922.90 |
Volume15,42,160 | Avg. traded₹892.60 | Revenue (12m)₹1,051 Crs |
Suven PharmaceuticalsSuven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe, and others. In India, the Company sells bulk drugs and intermediates, chemicals, and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.
Suven Pharmaceuticals Key indicators
52 week high₹922.90 | 52 week low₹481.65 | P/E ratio73.45 |
P/B ratio10.88 | ROE16.03% | ROCE21.27% |
Dividend yield-- | Debt/Equity ratio0.02 | EPS11.97 |
Learn more
Featured in
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin45.37% | Net profit margin29.74% |
ROE16.03% | ROA13.73% |
ROCE21.27% |
Learn more
Suven Pharmaceuticals Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Wed, Jul 24 2024 | ₹855.40 | ₹880.30 | |
Tue, Jul 23 2024 | ₹851.00 | ₹867.10 | |
Mon, Jul 22 2024 | ₹820.60 | ₹847.55 | |
Fri, Jul 19 2024 | ₹869.20 | ₹820.60 | -5.93% |
Thu, Jul 18 2024 | ₹855.60 | ₹872.30 | |
Tue, Jul 16 2024 | ₹841.00 | ₹858.60 | |
Mon, Jul 15 2024 | ₹850.00 | ₹841.15 | -0.82% |
Fri, Jul 12 2024 | ₹854.55 | ₹848.10 | -0.70% |
Events
Corporate actions
Dividend • ₹1/share
Ex date 09 Sep 2022
Dividend • ₹5/share
Ex date 09 Sep 2022
Dividend • ₹1/share
Ex date 13 May 2022
Dividend • ₹1/share
Ex date 13 May 2022
Dividend • ₹1/share
Ex date 15 Feb 2022
Dividend • ₹2/share
Ex date 15 Feb 2022
Learn more